BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 24588265)

  • 21. The impact of granulocyte colony stimulating factor at content of donor lymphocytes collected for cellular immunotherapy.
    Arat M; Arslan O; Gürman G; Dalva K; Ozcan M; Uğur A; Ilhan O
    Transfus Apher Sci; 2004 Feb; 30(1):9-15. PubMed ID: 14746816
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Single-dose pegfilgrastim for the mobilization of allogeneic CD34+ peripheral blood progenitor cells in healthy family and unrelated donors.
    Kroschinsky F; Hölig K; Poppe-Thiede K; Zimmer K; Ordemann R; Blechschmidt M; Oelschlaegel U; Bornhauser M; Rall G; Rutt C; Ehninger G
    Haematologica; 2005 Dec; 90(12):1665-71. PubMed ID: 16330441
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Collection of peripheral blood progenitor cells on Day 4 is feasible and effective while reducing granulocyte-colony-stimulating factor exposure to healthy donors.
    Flommersfeld S; Sohlbach K; Jaques G; Bein G; Hoffmann J; Kostrewa P; Sachs UJ
    Transfusion; 2015 Jun; 55(6):1269-74. PubMed ID: 25647638
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence that donor intrinsic response to G-CSF is the best predictor of acute graft-vs-host disease following allogeneic peripheral blood stem cell transplantation.
    Dhédin N; Chamakhi I; Perreault C; Roy DC; Sauvageau G; Ducruet T; Busque L; Fish D; Bélanger R; Roy J
    Exp Hematol; 2006 Jan; 34(1):107-14. PubMed ID: 16413397
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mobilization and engraftment of peripheral blood stem cells in healthy related donors >55 years old.
    Motlló C; Sancho JM; Grífols JR; Juncà J; Morgades M; Ester A; Rodríguez I; Vives S; Batlle M; Guardia R; Ferrà C; Gallardo D; Millá F; Feliu E; Ribera JM
    Cytotherapy; 2014 Mar; 16(3):406-11. PubMed ID: 24176544
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors affecting PBSC mobilization and collection in healthy donors.
    Lysák D; Koza V; Jindra P
    Transfus Apher Sci; 2005 Nov; 33(3):275-83. PubMed ID: 16209935
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biosimilar granulocyte-colony-stimulating factor for mobilization of autologous peripheral blood stem cells in pediatric hematology-oncology patients.
    Cesaro S; Tridello G; Prete A; Dallorso S; Cannata E; Massaccesi E; Risso M; De Bortoli M; Caselli D
    Transfusion; 2015 Feb; 55(2):246-52. PubMed ID: 25070657
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lenograstim-mobilized peripheral blood progenitor cells in volunteer donors: an open label randomized split dose escalating study.
    Basara N; Schmetzer B; Blau IW; Bischoff M; Günzelmann S; Kirsten D; Fauser AA
    Bone Marrow Transplant; 2000 Feb; 25(4):371-6. PubMed ID: 10723579
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Factors impacting yield of CD34(+) cells from healthy donors mobilized with rhG-CSF].
    Zhu L; Zhou LK; Xue M; Yan HM; Liu J; Wang ZD; Ding L; Wang HX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Dec; 17(6):1541-5. PubMed ID: 20030943
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The effect of matrix metalloproteinase-9 in granulocyte colony stimulation factor-induced stem cell mobilization].
    Jin FY; Qiu LG; Li QC; Meng HX; Wang YF; Yu Z; Li Q; Han JL
    Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(42):2966-70. PubMed ID: 17288807
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
    Arora M; Burns LJ; Barker JN; Miller JS; Defor TE; Olujohungbe AB; Weisdorf DJ
    Biol Blood Marrow Transplant; 2004 Jun; 10(6):395-404. PubMed ID: 15148493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized comparison of once versus twice daily recombinant human granulocyte colony-stimulating factor (filgrastim) for stem cell mobilization in healthy donors for allogeneic transplantation.
    Kröger N; Renges H; Krüger W; Gutensohn K; Löliger C; Carrero I; Cortes L; Zander AR
    Br J Haematol; 2000 Dec; 111(3):761-5. PubMed ID: 11122135
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and efficacy of healthy volunteer stem cell mobilization with filgrastim G-CSF and mobilized stem cell apheresis: results of a prospective longitudinal 5-year follow-up study.
    Mueller MM; Bialleck H; Bomke B; Brauninger S; Varga C; Seidl C; Seifried E; Tonn T; Bonig H
    Vox Sang; 2013 Jan; 104(1):46-54. PubMed ID: 22827736
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peripheral blood CD34+ cell enumeration as a predictor of apheresis yield: an analysis of more than 1,000 collections.
    Gambell P; Herbert K; Dickinson M; Stokes K; Bressel M; Wall D; Harrison S; Prince HM
    Biol Blood Marrow Transplant; 2012 May; 18(5):763-72. PubMed ID: 22227589
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of peripheral blood stem cell collection in elderly donors; does age interfere?
    Lysák D; Kořístek Z; Gašová Z; Skoumalová I; Jindra P
    J Clin Apher; 2011; 26(1):9-16. PubMed ID: 21312254
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pre-mobilization therapy blood CD34+ cell count predicts the likelihood of successful hematopoietic stem cell mobilization.
    Fu P; Bagai RK; Meyerson H; Kane D; Fox RM; Creger RJ; Cooper BW; Gerson SL; Laughlin MJ; Koc ON; Lazarus HM
    Bone Marrow Transplant; 2006 Aug; 38(3):189-96. PubMed ID: 16850032
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hematopoietic progenitor cell mobilization is more robust in healthy African American compared to Caucasian donors and is not affected by the presence of sickle cell trait.
    Panch SR; Yau YY; Fitzhugh CD; Hsieh MM; Tisdale JF; Leitman SF
    Transfusion; 2016 May; 56(5):1058-65. PubMed ID: 27167356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factors predicting peripheral blood progenitor cell collection from pediatric donors for allogeneic transplantation.
    Díaz MA; Sevilla J; de la Rubia J; Verdeguer A; Espigado I; Vicent MG; Pascual MJ; Zamora C; Arrieta R; Serrano D; del Cañizo C; Arbona C; de Arriba F; Bargay J; Brunet S; Sanz MA
    Haematologica; 2003 Aug; 88(8):919-22. PubMed ID: 12935980
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical study of single-dose G-CSF in mobilization and reconstruction of allogeneic peripheral blood stem cell transplantation].
    Tian H; Zhou SY
    Ai Zheng; 2003 Dec; 22(12):1325-9. PubMed ID: 14693061
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Filgrastim mobilization and collection of allogeneic blood progenitor cells from adult family donors: first interim report of a prospective German multicenter study.
    Beelen DW; Ottinger H; Kolbe K; Pönisch W; Sayer HG; Knauf W; Stockschläder M; Scheid C; Schaefer UW
    Ann Hematol; 2002 Dec; 81(12):701-9. PubMed ID: 12483366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.